Oxcarbazepine
Product Images NDC 50090-5003

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 50090-5003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500905003)

The packaging label for OXCARBAZEPINE 300 MG by A-S Medication Solutions. It indicates each film-coated tablet contains 300 mg of oxcarbazepine, with storage instructions to keep between 68 to 77 degrees Fahrenheit. The package holds 33 unit dose tablets. Additional details include lot and product numbers, a barcode, and distributor information in Lynwood, Illinois.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

Chemical structure of oxcarbazepine showing a dibenzazepine ring system with a ketone group and an amide side chain.*

FDA Label Image

Figure 1 (Oxcarbazepine 02)

A Kaplan-Meier curve graph depicting exit rates over time on trial from Day 2 to Day 11. Two treatment groups are compared: Oxcarbazepine (solid line) and Placebo (dotted line). The graph shows higher exit rates for the Placebo group versus Oxcarbazepine. A log-rank test p-value of 0.0001 is noted, indicating statistical comparison.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

A Kaplan-Meier survival curve chart displaying seizure rate over days from first dose to first seizure for two treatment groups: Oxcarbazepine and Placebo. The x-axis shows time in days, and the y-axis shows seizure rate ranging from 0 to 1. The chart includes a log-rank test p-value of 0.046 comparing the two groups.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

A Kaplan-Meier exit rate survival curve showing time to exit in days for two treatment groups labeled HIGH and LOW. The y-axis represents the exit rate from 0 to 1, and the x-axis shows time to exit in days up to 130. The solid line corresponds to the HIGH treatment group and the dotted line to the LOW group. A log-rank test p-value of 0.0001 is indicated on the chart.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

A Kaplan-Meier survival curve graph showing exit rates over time in days for two treatment groups labeled 'HIGH' (solid line) and 'LOW' (dotted line). The graph includes a log-rank test with a p-value of 0.0001, indicating statistical comparison between the groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.